The role of statins in delaying Alzheimer’s disease. Circulating cholesterol levels, ApoE genotype and initial dementia severity influence the level of benefit produced by atorvastatin in mild-to-moderate AD: Results of the ADCLT
D. Larry Sparks; Donald J. Connor; Marwan N. Sabbagh; Jean Lopez; Patrick Browne; Bob Petersen; Dawn Wasser; Sherry Johnson-Traver
- 作者D. Larry Sparks; Donald J. Connor; Marwan N. Sabbagh; Jean Lopez; Patrick Browne; Bob Petersen; Dawn Wasser; Sherry Johnson-Traver
- 卷第1卷
- 文件大小44.80KB
- 发表时间2005
- DOI10.1016/j.jalz.2005.06.321